Welcome To The Mannkind HUB On AGORACOM
Edit this title from the Fast Facts Section
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

AGORACOM Small Cap TV “Best Of The Best” – 2014 Tax Loss Selling Stock Picking Contest

Tax loss selling season is upon us once again and you know what that means … George vs Allan Stock Picking Contest!!  In this special episode of AGORACOM TV, George (Founder) and Allan (Chief Market Commentator) give their Top 5 Tax Loss Selling Candidates (+ 1 Bonus Pick) that are most likely to provide a pop to their portfolios by January 30, 2015. 

WATCH IT NOW!

Message: Afrezza sales could be higher than Exubera, says Summer Street

Barney-fife-crop-fix
Rank: [?]
President
Points: [?]
5496
Rating: [?]
Votes: 21 Score: 4.5
  • Currently 4.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Afrezza sales could be higher than Exubera, says Summer Street

posted on Jul 16, 13 09:52AM

"Summer Street believes that if approved, sales of MannKind's (MNKD) inhalable insulin Afrezza could be "substantially higher" than Pfizer’s (PFE) Exubera given Afrezza’s ease of use. However, the firm adds that it cannot accurately predict future sales of Afrezza at this time."

http://www.theflyonthewall.com/permalinks/entry.php/MNKD;PFEid1858409/MNKD;PFE-Afrezza-sales-could-be-higher-than-Exubera-says-Summer-Street

New Message

Please login to post a reply

AGORACOM Quick Tips

Bullish On China? AGORACOM Launches ChinaSecurities.com ... Check It Out
Watch
Today's Show
in 00:00:000

President's D.D.

Here's the latest Griffin report read more

Stock Quote

Hub Leaders